QT variability strongly predicts sudden cardiac death in asymptomatic subjects with mild or moderate left ventricular systolic dysfunction: A prospective study

European Heart Journal

Volumn 28, Issue 11, 2007, Pages 1344-1350

  Piccirillo, Gianfranco ^a   Magrì, Damiano ^a   Matera, Sabrina ^a   Magnanti, Marzia ^a   Torrini, Alessia ^a   Pasquazzi, Eleonora ^a   Schifano, Erika ^a   Velitti, Stefania ^a   Marigliano, Vincenzo ^a   Quaglione, Raffaele ^a   Barillà, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Autonomic nervous system; Chronic heart failure; QT dynamic; QT variability; Sudden cardiac death

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FEMALE; HAZARD RATIO; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FAILURE; HEART RATE VARIABILITY; HEART REPOLARIZATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QT INTERVAL; RISK ASSESSMENT; SUDDEN DEATH; SURVIVAL;

AGED; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; LONG QT SYNDROME; MALE; PROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34548398572     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl367     Document Type: Article

References (27)

1. American College of Cardiology/American Heart Association task force. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in adult. Circulation 2005;112:1825-1852.
2. Task force members for the diagnosis and treatment of chronic heart failure of European Heart Association. Guideline for the diagnosis and treatment: (full text) of chronic heart failure (2005 guideline). Eur Heart J 2005;26:384-416.
3. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Eng J Med 1996;335:1933-1940.
4. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
5. Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, O'Toole MF, Tang A, Fisher JD, Coromilas J, Talajic M, Hafley G. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 2000;342:1937-1945.
6. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237.
7. Goldeberger Z, Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA 2006;295:809-818.
8. Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Wang D, Pocock S, Pffer MA, Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 2005;112:3738-3744.
9. Stecker EC, Vickers C, Waltz J, Socoteanu C, John BT, Mariani R, McAnulty JH, Gunson K, Jui J, Chugh SS. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol 2006;47:1161-1166.
10. Haigney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, McNitt S, Andrews ML, Moss AJ. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II. J Am Coll Cardiol 2004;44:1481- 1487.
11. Atiga WL, Calkins H, Lawrence JH, Tomaselli GF, Smith JM, Berger RD. Beat-to-beat repolarization lability identifies patients at risk for sudden cardiac death. J Cardiovasc Electrophysiol 1998;9:899-908.
12. Piccirillo G, Germanò G, Quaglione R, Nocco M, Lintas F, Lionetti M, Moisè A, Ragazzo M, Marigliano V, Cacciafesta M. QT-interval variability and autonomic control in hypertensive subjects with left ventricular hypertrophy. Clin Sci 2002;102:363-371.
13. Berger RD, Kasper EK, Baughman KL, Marban E, Calkins H, Tomaselli GF. Beat-to-beat QT interval variability. Novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation 1997;96:1557-1565.
14. Piccirillo G, Cacciafesta M, Lionetti M, Nocco M, Di Giuseppe V, Moisè A, Naso C, Marigliano V. The influence of age, the autonomic nervous system and anxiety on QT interval variability. Clin Sci 2001;101:429-438.
15. Piccirillo G, Quaglione R, Nocco M, Naso C, Moisè A, Lionetti M, Di Carlo S, Marigliano V. Effects of long-term β-blocker therapy on QT variability index in subjects with chronic heart failure. Am J Cardiol 2002;90:1113-1117.
16. Piccirillo G, Magnanti M, Matera S, Di Carlo S, De Laurentis T, Torrini A, Marchitto N, Ricci R, Magrì D. Age and QT variability index during free breathing, controlled breating and tilt in patient with chronic heart failure and healthy control subjects. Transl Res 2006;148:72-78.
17. Bazett HC. An analysis of the time relations of electrocardiograms. Heart 1920;7:353-370.
18. List of three-digit categories. International classification of diseases, injuries and causes of death. 9th rev. Gineve: Word Health Organization; 1967. Vol. 1, p3-41.
19. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurements. Lancet 1986;8:307-310.
20. Mosterd A, Hoes AW, de Bryne MC, Deckers JW, Linker A, Hofman, Grobbee DE. Prevalence of heart left ventricular dysfunction in the general population. The Rotterdam Study. Eur Heart J 1999;14:1441-1446.
21. Auricchio A, Abraham WT. Cardiac resynchronization therapy: current state of the art: cost versus benefit. Circulation 2004;109:300-307.
22. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150.
23. Antzelevitch C, Oliva A. Amplification of spatial dispersion of repolarization underlies sudden cardiac death associated with catecholaminergic polymorphic VT, long QT, short QT and Brugada syndromes. J Int Med 2006;259:48-58.
24. Rosen MR, Cohen IS. Molecular/genetic determinants of repolarization and their modification by environmental stress. J Int Med 2006;259:7-23.
25. Tomaselli GF, Zipes DP. What causes sudden death in heart failure? Circ Res 2004;95:754-763.
26. Everett TH, Wilson EE, Foreman S, Olgin JE. Mechanisms of ventricular fibrillation in canine model of congestive heart failure and ischemia assessed by in vivo noncontact mapping. Circulation 2005;112:1532-1541.
27. La Rovere MT, Pinna GD, Maestri R, Mortara A, Capomolla S, Febo O, Ferrari R, Franchini M, Gemmi M, Opasich C, Riccardi PG, Traversi E, Corbelli F. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 2003;107:565-570.